Explore a rare case of systemic mastocytosis in a young adult, highlighting its role in unexplained osteoporosis and the need ...

This report highlights the diagnostic challenges of SM, emphasize its underrecognized role in osteoporosis and fragility fractures, and advocates for ...

Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT net product revenue of ...

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...

THB335 showed dose-dependent serum tryptase reductions from 13% to 84% at Day 15, supporting its advancement to Phase 2 in ...

James made a notable change in their assessment of Third Harmonic (NASDAQ:HLIT) Bio (NASDAQ:THRD), downgrading the biotechnology company's stock rating from Outperform to Market Perform. According to ...

Bio, Inc. (NASDAQ: THRD) plummeted 35% following the announcement of Phase 1 clinical trial results for its drug candidate ...

Third Harmonic Bio (THRD) announced results from its Phase 1 single and multiple ascending dose clinical trial of THB335 in healthy volunteers.

A mild positive food effect was observed as well. Pharmacodynamics Dose-dependent reductions in serum tryptase, a biomarker of mast cell activation, were observed in the MAD cohorts, with mean ...

A MUM suffering severe bloating died after she had a suspected allergic reaction to a CT scan. Yvonne Graham, 66, went into cardiac arrest minutes after medics at Northampton General Hospital ...